CoChat
Sign Up
Cited by 187

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial

Preiss, David, Lloyd, Suzanne M, Ford, Ian, McMurray, John J, Holman, Rury R, Welsh, Paul, Fisher, Miles, Packard, Chris J, Sattar, Naveed·2014·The Lancet Diabetes & Endocrinology
DOI 10.1016/s2213-8587(13)70152-9
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(13)70152-9

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CAMERA trial showed no effect of metformin on carotid intimal medial thickness.

    “and the CAMERA trial (Preiss et al., 2014) showed no effect of metformin (18 months) on carotid intimal medial thickness.”

    From Metformin as a tool to target aging (2016) · cites this paper as Preiss et al., 2014

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. Eddy, 2009, Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis, Diabetes Care, 32, 361, 10.2337/dc08-0854 · DOI
  2. Despres, 1996, Hyperinsulinemia as an independent risk factor for ischemic heart disease, N Engl J Med, 334, 952, 10.1056/NEJM199604113341504 · DOI · Paper page
  3. Grundy, 2004, Obesity, metabolic syndrome, and cardiovascular disease, J Clin Endocrinol Metab, 89, 2595, 10.1210/jc.2004-0372 · DOI
  4. Bird, 2013, Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines, Gynecol Endocrinol, 29, 365, 10.3109/09513590.2012.743007 · DOI
  5. Seifarth, 2013, Effectiveness of metformin on weight loss in non-diabetic individuals with obesity, Exp Clin Endocrinol Diabetes, 121, 27
  6. Fontbonne, 1996, The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group, Diabetes Care, 19, 920, 10.2337/diacare.19.9.920 · DOI
  7. 1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8 · DOI · Paper page
  8. Alberti, 2006, Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation, Diabet Med, 23, 469, 10.1111/j.1464-5491.2006.01858.x · DOI · Paper page
  9. Vergeer, 2010, Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies, Circ Cardiovasc Imaging, 3, 398, 10.1161/CIRCIMAGING.109.909655 · DOI
  10. 2010, Standards of medical care in diabetes—2010, Diabetes Care, 33, S11
  11. Touboul, 2004, Mannheim intima-media thickness consensus, Cerebrovasc Dis, 18, 346, 10.1159/000081812 · DOI · Paper page
  12. Liang, 2000, A multiscale dynamic programming procedure for boundary detection in ultrasonic artery images, IEEE Trans Med Imaging, 19, 127, 10.1109/42.836372 · DOI
  13. Spence, 2006, Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies, Int J Stroke, 1, 216, 10.1111/j.1747-4949.2006.00068.x · DOI
  14. Meaney, 2008, Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study, Clin Exp Pharmacol Physiol, 35, 895, 10.1111/j.1440-1681.2008.04920.x · DOI
  15. Taylor, 2002, ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness, Circulation, 106, 2055, 10.1161/01.CIR.0000034508.55617.65 · DOI
  16. Selvin, 2008, Cardiovascular outcomes in trials of oral diabetes medications: a systematic review, Arch Intern Med, 168, 2070, 10.1001/archinte.168.19.2070 · DOI · Paper page
  17. Sjöström, 1998, Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients, Lancet, 352, 167, 10.1016/S0140-6736(97)11509-4 · DOI · Paper page
  18. Shyangdan, 2011, Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review, Health Technol Assess, 15, 1, 10.3310/hta15380 · DOI
  19. Bots, 2003, Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view, Stroke, 34, 2985, 10.1161/01.STR.0000102044.27905.B5 · DOI
  20. Taylor, 2009, Extended-release niacin or ezetimibe and carotid intima-media thickness, N Engl J Med, 361, 2113, 10.1056/NEJMoa0907569 · DOI
  21. Huang, 2013, Effect of statin therapy on the progression of common carotid artery intima-media thickness: an updated systematic review and meta-analysis of randomized controlled trials, J Atheroscler Thromb, 20, 108, 10.5551/jat.14001 · DOI · Paper page
  22. Lorenz, 2012, Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data, Lancet, 379, 2053, 10.1016/S0140-6736(12)60441-3 · DOI · Paper page
  23. Mazzone, 2006, Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial, JAMA, 296, 2572, 10.1001/jama.296.21.joc60158 · DOI · Paper page
  24. Taylor, 2009, Extended-release niacin or ezetimibe and carotid intima-media thickness, N Engl J Med, 361, 2113, 10.1056/NEJMoa0907569 · DOI
  25. Lonn, 2013, Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE), Diabetes Care, 36, 2466, 10.2337/dc12-2129 · DOI
  26. Lexis, 2012, Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial, Cardiovasc Drugs Ther, 26, 417, 10.1007/s10557-012-6413-1 · DOI

Cited by

Sorted by citations

Metadata

Authors
Preiss, D., Lloyd, S. M., Ford, I., McMurray, J. J., Holman, R. R., Welsh, P., Fisher, M., Packard, C. J., & Sattar, N.
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2014-02
Volume
2
Issue
2
Pages
116-124
ISSN
2213-8587
DOI
10.1016/s2213-8587(13)70152-9
Cited by
187
References
11
Language
en
Licence
Funders
Chief Scientist Office (CZB/4/613)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review